Nektar Therapeutics (NKTR) EBT (2010 - 2026)
Nektar Therapeutics' (NKTR) quarterly EBT came in at -$43.1 million in Q1 2026, up 7.07% year-on-year from -$40.2 million in Q1 2025, and down 24.17% quarter-over-quarter from -$34.7 million in Q4 2025.
Nektar Therapeutics (NKTR) EBT (2010 - 2026) Analysis & Trends
Nektar Therapeutics' EBT history runs 17 years deep, the most recent figure standing at -$43.1 million for Q1 2026.
- On a quarterly basis, EBT rose 7.07% year-over-year to -$43.1 million in Q1 2026; TTM through Mar 2026 was -$152.2 million, a 18.24% decrease from a year earlier, with the FY2025 full-year figure at -$155.5 million, down 30.44% from the prior year.
- EBT slipped to -$43.1 million in Q1 2026 per NKTR's latest filing, from -$34.7 million in the prior quarter.
- Across five years, EBT topped out at $7.0 million in Q4 2024 and bottomed at -$159.0 million in Q2 2022.
- The 5-year median for EBT is -$45.9 million (2023), against an average of -$56.4 million.
- Across the five-year window, EBT soared 116.63% in 2024 and plunged 595.6% in 2025, its largest moves.
- Year by year, EBT stood at -$56.5 million in 2022, then increased by 25.53% to -$42.1 million in 2023, then soared by 116.63% to $7.0 million in 2024, then plunged by 595.6% to -$34.7 million in 2025, then fell by 24.17% to -$43.1 million in 2026.
- Per Business Quant, the three latest NKTR EBT figures stand at -$43.1 million (Q1 2026), -$34.7 million (Q4 2025), and -$35.0 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Nektar Therapeutics | 2.04 Bn | 1.48 Bn | 3.16 Mn | -43.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.09 Mn |
| Dec 31, 2025 | -34.70 Mn |
| Sep 30, 2025 | -35.02 Mn |
| Jun 30, 2025 | -39.40 Mn |
| Mar 31, 2025 | -46.37 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | -37.05 Mn |
| Jun 30, 2024 | -52.32 Mn |
| Mar 31, 2024 | -36.84 Mn |
| Dec 31, 2023 | -42.11 Mn |
| Sep 30, 2023 | -45.90 Mn |
| Jun 30, 2023 | -51.17 Mn |
| Mar 31, 2023 | -137.08 Mn |
| Dec 31, 2022 | -56.54 Mn |
| Sep 30, 2022 | -59.20 Mn |
| Jun 30, 2022 | -158.97 Mn |
| Mar 31, 2022 | -90.27 Mn |
| Dec 31, 2021 | 378.79 Mn |
| Sep 30, 2021 | -129.59 Mn |
| Jun 30, 2021 | -125.16 Mn |